La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Lantheus Holdings Gestione
Gestione criteri di controllo 2/4
Lantheus Holdings' Il CEO è Brian Markison, nominato in Mar2024, ha un mandato di meno di un anno. possiede direttamente 0.025% delle azioni della società, per un valore di $ 1.63M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.8 anni e 6.5 anni.
Informazioni chiave
Brian Markison
Amministratore delegato
US$539.1k
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | 0.02% |
| Durata media del management | 1.8yrs |
| Durata media del Consiglio di amministrazione | 6.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Lantheus: A Radiopharmaceutical Powerhouse In The Making (Q2 2024 Update)
Aug 12Here's Why Lantheus Holdings (NASDAQ:LNTH) Has Caught The Eye Of Investors
Aug 05
Investors Appear Satisfied With Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Prospects As Shares Rocket 49%
Jul 17Lantheus Holdings (NASDAQ:LNTH) Is Investing Its Capital With Increasing Efficiency
Jul 16Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt
Jun 24Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus
May 23Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce
May 10Lantheus Holdings: Powerful First Quarter
May 05Investors Should Be Encouraged By Lantheus Holdings' (NASDAQ:LNTH) Returns On Capital
Apr 12Lantheus Holdings: Undervalued With A Good Outlook
Feb 28Lantheus Holdings, Inc.'s (NASDAQ:LNTH) P/S Is Still On The Mark Following 26% Share Price Bounce
Feb 24Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly
Feb 08Market Participants Recognise Lantheus Holdings, Inc.'s (NASDAQ:LNTH) Earnings
Jan 03Return Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Appealing
Dec 16A Look At The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)
Nov 28Is Lantheus Holdings (NASDAQ:LNTH) Using Too Much Debt?
Nov 09Returns At Lantheus Holdings (NASDAQ:LNTH) Appear To Be Weighed Down
Sep 04Calculating The Fair Value Of Lantheus Holdings, Inc. (NASDAQ:LNTH)
Aug 09Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?
Jul 22Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively
May 29Here's Why Lantheus Holdings (NASDAQ:LNTH) Can Manage Its Debt Responsibly
Apr 16Capital Allocation Trends At Lantheus Holdings (NASDAQ:LNTH) Aren't Ideal
Feb 27An Intrinsic Calculation For Lantheus Holdings, Inc. (NASDAQ:LNTH) Suggests It's 48% Undervalued
Jan 16Lantheus Holdings (NASDAQ:LNTH) Could Easily Take On More Debt
Dec 24Lantheus Holdings (NASDAQ:LNTH) Might Be Having Difficulty Using Its Capital Effectively
Oct 31Does This Valuation Of Lantheus Holdings, Inc. (NASDAQ:LNTH) Imply Investors Are Overpaying?
Oct 04Looking In On Lantheus Holdings
Sep 14Lantheus Holdings a buy at B Riley on growth spurred by approval of imaging agent
Aug 25Lantheus Non-GAAP EPS of $0.89 beats by $0.19, revenue of $223.72M beats by $19.21M
Aug 04Lantheus Holdings (NASDAQ:LNTH) May Have Issues Allocating Its Capital
Jul 22AMMINISTRATORE DELEGATO
Brian Markison (65 yo)
less than a year
Mandato
US$539,112
Compensazione
Mr. Brian A. Markison has served as Chairman of the Board and Chief Executive Officer of Osmotica Pharmaceutical Corp. since 2016. Mr. Markison had been an Operating Executive and Healthcare Industry Execu...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | less than a year | US$539.11k | 0.025% $ 1.7m | |
| President | 1.4yrs | US$5.31m | 0.14% $ 9.7m | |
| CFO & Treasurer | 5.9yrs | US$4.33m | 0.16% $ 11.1m | |
| Chief Science Officer | less than a year | US$3.08m | 0.0083% $ 561.2k | |
| Chief Administrative Officer | 3.6yrs | US$3.12m | 0.11% $ 7.6m | |
| Chief Accounting Officer | less than a year | Nessun dato | Nessun dato | |
| Senior Vice President of Manufacturing & Technical Operations | 2.2yrs | Nessun dato | Nessun dato | |
| Senior Director of Investor Relations | no data | Nessun dato | Nessun dato | |
| VP of Corporate Communications & Chief of Staff | 4yrs | Nessun dato | Nessun dato | |
| Chief People Officer | less than a year | Nessun dato | Nessun dato | |
| Senior Vice President of Quality | 6.3yrs | Nessun dato | Nessun dato | |
| Chief Commercial Officer | 1.8yrs | Nessun dato | 0.037% $ 2.5m |
1.8yrs
Durata media
57yo
Età media
Gestione esperta: Il team dirigenziale di LNTH non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 11.9yrs | US$539.11k | 0.025% $ 1.7m | |
| Independent Director | 12.3yrs | US$493.31k | 0.087% $ 5.9m | |
| Independent Director | 6.5yrs | US$483.39k | 0.044% $ 3.0m | |
| Chairman of the Board | 9yrs | US$12.58m | 0.84% $ 57.3m | |
| Independent Director | 2.4yrs | US$477.89k | 0.0043% $ 294.9k | |
| Independent Director | 4.2yrs | US$470.81k | 0.027% $ 1.8m | |
| Lead Independent Director | 7.6yrs | US$479.11k | 0.035% $ 2.3m | |
| Independent Director | 6.5yrs | US$493.31k | 0.029% $ 2.0m | |
| Independent Director | 4.2yrs | US$480.00k | 0.036% $ 2.4m |
6.5yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di LNTH sono considerati esperti (durata media dell'incarico 6.5 anni).